Stanley Nattel1. Show Affiliations » 1. Cardiovascular Electrophysiology, University of Montreal and the Montreal Heart Institute, Montreal, Quebec, Canada. Stanley.nattel@icm-mhi.org
Abstract
Entities: Chemical Disease Species
Mesh： See more » AgedAged, 80 and overAngiotensin II Type 1 Receptor Blockers/therapeutic useAnti-Arrhythmia Agents/therapeutic useAtenolol/therapeutic useAtrial Fibrillation/etiologyAtrial Fibrillation/physiopathologyAtrial Fibrillation/prevention & controlBlood Pressure/drug effectsDouble-Blind MethodElectrocardiographyFollow-Up StudiesHeart Rate/drug effectsHumansHypertension/complicationsHypertension/drug therapyHypertension/physiopathologyLosartan/therapeutic useMiddle AgedProspective StudiesTreatment Outcome
Substances： See more » Angiotensin II Type 1 Receptor BlockersAnti-Arrhythmia AgentsAtenololLosartan
Year: 2005 PMID： 16265553 DOI： 10.1038/ncpcardio0247
Source DB: PubMed Journal: Nat Clin Pract Cardiovasc Med ISSN： 1743-4297